GenomeMe Lab Inc.
GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical IHC antibodies in-house, making us the first and only institution to date to achieve this. We are on track to reach this R&D goal by the end of 2021 - hitting a monumental milestone in the history of our company’s development. Because we develop and manufacture all of our antibodies in-house, we are able to offer our distributors, OEM partners, and valuable end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
Why Choose GenomeMe?
- Wholesale Prices
- Stringent Quality Control Processes
- Satisfaction Guaranteed
- Advanced Technologies
Our Mission
To advance precision diagnostics through quality IHC antibodies.
Technologies
qPCR
qPCR is the gold standard in diagnostics, providing rapid, specific, and sensitive detection.
Next Generation Sequencing
We combine hybridoma and Next Generation Sequencing technologies to successfully develop mouse and rabbit monoclonal antibodies for clinical applications.
Immunohistochemistry
Our immunohistochemistry staining and Microtome equipment enable us to rapidly screen, validate, and QC our molecular pathology portfolio.